BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,029 | +12.2% | 20,502 | +41.2% | 0.00% | 0.0% |
| Q2 2023 | $917 | +6953.8% | 14,524 | +4908.3% | 0.00% | – |
| Q1 2023 | $13 | -100.0% | 290 | -88.7% | 0.00% | – |
| Q1 2022 | $164,000 | +241.7% | 2,569 | +366.2% | 0.00% | – |
| Q3 2021 | $48,000 | 0.0% | 551 | 0.0% | 0.00% | – |
| Q2 2021 | $48,000 | – | 551 | +8.5% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 508 | +408.0% | 0.00% | – |
| Q1 2020 | $5,000 | -96.9% | 100 | -95.5% | 0.00% | – |
| Q3 2019 | $161,000 | -43.3% | 2,198 | -51.0% | 0.00% | -100.0% |
| Q2 2018 | $284,000 | +195.8% | 4,484 | +249.2% | 0.00% | -75.0% |
| Q4 2017 | $96,000 | -41.5% | 1,284 | -68.7% | 0.00% | -42.9% |
| Q1 2017 | $164,000 | +1540.0% | 4,106 | +1009.7% | 0.01% | +600.0% |
| Q3 2016 | $10,000 | +900.0% | 370 | +386.8% | 0.00% | – |
| Q2 2016 | $1,000 | -96.3% | 76 | -92.6% | 0.00% | -100.0% |
| Q4 2015 | $27,000 | +800.0% | 1,026 | +460.7% | 0.00% | – |
| Q3 2015 | $3,000 | – | 183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |